Click Therapeutics

company

About

Click Therapeutics delivers safe and effective digital treatments to patients in need.

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Medical Device,Pharmaceutical,Therapeutics
Founded date
Apr 1, 2012
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Click Therapeutics, Inc.

Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
11
$0.92B
Click Therapeutics has raised a total of $0.92B in funding over 2 rounds. Their latest funding was raised on Apr 15, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 15, 2022 Debt Financing $15M 1 Silicon Valley Bank Detail
Oct 22, 2021 Series B $52M 8 Accelmed
H.I.G. BioHealth Partners
Detail
Dec 1, 2020 Debt Financing $30M 1 K2 HealthVentures Detail
Sep 11, 2020 Funding Round $500M 1 Boehringer Ingelheim Detail
Dec 11, 2018 Funding Round $302M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Click Therapeutics has made 1 investments. Their most recent investment was on May 1, 2020, when Clocr raised $750K.
Date Company Name
Round Money Raised Industry Lead Investor
May 1, 2020 Clocr
Seed $750K B2B

Investors

Number of Lead Investors
Number of Investors
7
15
Click Therapeutics is funded by 15 investors. Silicon Valley Bank and Accelmed are the most recent investors.
Investor Name Lead Investor Funding Round
Silicon Valley Bank Yes Debt Financing
Accelmed Yes Series B
H.I.G. BioHealth Partners Yes Series B
Boehringer Ingelheim Yes Funding Round
Magellan Health Services Yes Convertable Note
Health Catalyst Capital Series B
Hikma Ventures Series B
K2 HealthVentures Series B
Revelation Partners Series B
Ridgetop Health Series B

Employee Profiles

Number of Employee Profiles
8
Click Therapeutics has 8 current employee profiles, including Board member Lee Shapiro
Board member
Board member
Board member
Executive

Acquisition

Click Therapeutics has acquired 1 organizations. Their most recent acquisition was ProGevity Neuroscience on Aug 6, 2012. They acquired ProGevity Neuroscience for 0.

Date Company Name
Industry Acquisition Type Price
Health Care acquisition Detail